Promediq'a Sp. z oo has been successfully operating on the Polish market for many years. The company's activity focuses on the development and sale of modern, top-quality products. Based on its experience in the field of pharmacy and proficiency in cosmetology, Promediq has created brands offering innovative lines of dietary supplements and exclusive biocosmetics for its clients.
As a company, we also specialize in contract manufacturing of dietary supplements and cosmetics. Depending on your needs, we not only produce, but also support our clients in finding optimal product solutions, we provide them with full advice regarding the selection of raw materials, preparation and production, and confection. Both the production volume and the dates of its production are each time adapted to the customer's requirements.
Customer loyalty is for us the basic measure of success and is the most important determinant confirming the quality of our services and the effectiveness of products. Customer satisfaction is the strongest motivation for the team of employees of the company to constantly improve the offer.
47.73.Z - Dispensing chemist in specialised stores
20.42.Z - Manufacture of perfumes and toilet preparations
46.38.Z - Wholesale of other food, including fish, crustaceans and molluscs
46.39.Z - Non-specialised wholesale of food, beverages and tobacco
46.45.Z - Wholesale of perfume and cosmetics
46.46.Z - Wholesale of pharmaceutical goods
46.75.Z - Wholesale of chemical products
46.76.Z - Wholesale of other intermediate products
47.75.Z - Retail sale of cosmetic and toilet articles in specialised stores
47.91.Z - Retail sale via mail order houses or via Internet
2018 | 2019 | 2020 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 2,6 | -0 | -101,6 | |
Gross profit (loss) | 0,4 | 3,2 | -0,1 | -101,9 |
EBITDA | 0,5 | 2,6 | -0 | -101,7 |
Short time liabilities | 1,4 | 107,4 | 107,5 | 0 |
Other operating costs | 0,4 | 0 | -95,6 | |
Equity capital | 0,6 | 3,2 | 3,1 | -1,4 |
Operating profit (EBIT) | 0,4 | 2,5 | -0,1 | -102,4 |
Assets | 2,2 | 110,8 | 110,8 | 0 |
Net profit (loss) | 0,3 | 2,6 | -0,1 | -102,4 |
Cash | 0,1 | 0 | 0 | -73,8 |
Net income from sale | 1,9 | 89,1 | 0 | -100 |
Liabilities and provisions for liabilities | 1,6 | 107,7 | 107,7 | 0 |
Working assets | 1,6 | 110,6 | 110,6 | 0 |
Other income costs | 0,3 | 0 | -100 | |
Depreciation | 0,1 | 0 | 0 | -67,1 |
% | % | % | p.p. | |
Profitability of capital | 48,5 | 80,9 | -1,9 | -82,8 |
Equity capital to total assets | 26,9 | 2,8 | 2,8 | 0 |
Gross profit margin | 18,8 | 3,6 | -556,9 | -560,5 |
EBITDA Margin | 25,4 | 2,9 | -407,9 | -410,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 270 | 440 | 3 620 219 | 3 619 779 |
Current financial liquidity indicator | 1.0297539234161377 | 1.029494285583496 | 0 | |
Net dept to EBITDA | 0.12178193032741547 | -7.6598381996154785 | -7,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane